Cargando…

Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase

Allosteric inhibitors of hepatitis C virus (HCV) non-structural protein 5B (NS5B) polymerase are effective for treatment of genotype 1, although their mode of action and potential to inhibit other isolates and genotypes are not well established. We have used biophysical techniques and a novel biosen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdurakhmanov, Eldar, Øie Solbak, Sara, Danielson, U. Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490826/ https://www.ncbi.nlm.nih.gov/pubmed/28621755 http://dx.doi.org/10.3390/v9060151

Ejemplares similares

Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA – effects on NS5B catalysis and allosteric inhibition
por: Solbak, Sara M. Ø., et al.
Publicado: (2017)

Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
por: Eltahla, Auda A., et al.
Publicado: (2015)

Biophysical Investigation of the Mode of Inhibition of Tetramic Acids, the Allosteric Inhibitors of Undecaprenyl Pyrophosphate Synthase
por: Lee, Lac V., et al.
Publicado: (2010)

Uncovering an allosteric mode of action for a selective inhibitor of human Bloom syndrome protein
por: Chen, Xiangrong, et al.
Publicado: (2021)

Structure based virtual screening of inhibitors for binding at the allosteric site of HCV RNA dependent RNA polymerase
por: Revikumar, Amjesh, et al.
Publicado: (2012)

Discovery of Beclabuvir: A Potent Allosteric Inhibitor of the Hepatitis C Virus Polymerase
por: Gentles, Robert G.
Publicado: (2018)

Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling
por: Lim, Siew Pheng, et al.
Publicado: (2016)

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2
por: Jha, Vibhu, et al.
Publicado: (2023)

Mechanisms of allosteric and mixed mode aromatase inhibitors
por: Souza, Samson A., et al.
Publicado: (2021)

Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6
por: Corona, Angela, et al.
Publicado: (2016)

Orally Efficacious Broad-Spectrum Allosteric Inhibitor of Paramyxovirus Polymerase
por: Cox, Robert M, et al.
Publicado: (2020)

Sensitive Protein Detection Using Site-Specifically Oligonucleotide-Conjugated Nanobodies
por: Al-Amin, Rasel A., et al.
Publicado: (2022)

Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors
por: Shang, Yi, et al.
Publicado: (2016)

Structural and Regulatory Elements of HCV NS5B Polymerase – β-Loop and C-Terminal Tail – Are Required for Activity of Allosteric Thumb Site II Inhibitors
por: Boyce, Sarah E., et al.
Publicado: (2014)

Inhibitor binding mode and allosteric regulation of Na(+)-glucose symporters
por: Bisignano, Paola, et al.
Publicado: (2018)

Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist
por: de Vries, Rens M. J. M., et al.
Publicado: (2020)

Biophysical analysis of the dynamics of calmodulin interactions with neurogranin and Ca(2+)/calmodulin‐dependent kinase II
por: Seeger, Christian, et al.
Publicado: (2017)

Affecting AMPA Receptor Biophysical Gating Properties with Negative Allosteric Modulators
por: Qneibi, Mohammad, et al.
Publicado: (2022)

The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function
por: Hebner, Christy M., et al.
Publicado: (2012)

Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors
por: Kaushik-Basu, Neerja, et al.
Publicado: (2008)

Amino acid substitutions in human growth hormone affect secondary structure and receptor binding
por: Rajkovic, Andrei, et al.
Publicado: (2023)

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
por: Quambusch, Lena, et al.
Publicado: (2019)

Computational Study on the Inhibitor Binding Mode and Allosteric Regulation Mechanism in Hepatitis C Virus NS3/4A Protein
por: Xue, Weiwei, et al.
Publicado: (2014)

Triple-action inhibitory mechanism of allosteric TYK2-specific inhibitors
por: Wang, Jimin, et al.
Publicado: (2023)

Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China
por: Zhou, Kali, et al.
Publicado: (2016)

Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function
por: Saalau-Bethell, Susanne M., et al.
Publicado: (2012)

Classification of HCV NS5B Polymerase Inhibitors Using Support Vector Machine
por: Wang, Maolin, et al.
Publicado: (2012)

Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors
por: Seixas, João D., et al.
Publicado: (2020)

Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition
por: Shunmugam, Letitia, et al.
Publicado: (2018)

Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode
por: Boffey, Helen K., et al.
Publicado: (2022)

Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking
por: Karpiński, Tomasz M., et al.
Publicado: (2023)

Allosteric Inhibitors of the NS3 Protease from the Hepatitis C Virus
por: Abian, Olga, et al.
Publicado: (2013)

Allosteric control of the RNA polymerase by the elongation factor RfaH
por: Svetlov, Vladimir, et al.
Publicado: (2007)

Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction
por: Moini, Maryam, et al.
Publicado: (2013)

Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action
por: Lückmann, Michael, et al.
Publicado: (2022)

Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development
por: Toth, Eric A., et al.
Publicado: (2021)

Conformation Selection by ATP-competitive Inhibitors and Allosteric Communication in ERK2
por: Anderson, Jake W., et al.
Publicado: (2023)

Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action
por: Huitema, Carly, et al.
Publicado: (2008)

A Cell-Based Assay for RNA Synthesis by the HCV Polymerase Reveals New Insights on Mechanism of Polymerase Inhibitors and Modulation by NS5A
por: Ranjith-Kumar, C. T., et al.
Publicado: (2011)

Minimal biophysical model of combined antibiotic action
por: Kavčič, Bor, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_je34o7fg9ndupsbts4qib7lbsf